5-溴-1-异丙基-1H-吲哚 | 675827-10-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 5-溴-1-异丙基-1H-吲哚
• 英文名称: 1-isopropyl-5-bromo-1H-indole
• 英文别名: 5-bromo-1-isopropyl-1H-indole；5-bromo-1-propan-2-ylindole
• CAS: 675827-10-8
• 化学式: C₁₁H₁₂BrN
• 分子量: 238.127
• InChiKey: NCPAGYRFULVTEU-UHFFFAOYSA-N

物化性质

• 沸点：
  311.8±15.0 °C(Predicted)
• 密度：
  1.36±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  4.9
• 氢给体数：
  0
• 氢受体数：
  0

安全信息

• 海关编码：
  2933990090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-Bromo-1-isopropyl-1H-indole
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Bromo-1-isopropyl-1H-indole
CAS number: 675827-10-8

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H12BrN
Molecular weight: 238.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-溴-1-异丙基-1H-吲哚 在 正丁基锂 、 palladium 10% on activated carbon 、 potassium carbonate 作用下， 以 四氢呋喃 、 正己烷 、 水 、 N,N-二甲基甲酰胺 、 乙腈 为溶剂， 反应 10.0h， 生成 2-(2-Amino-5-(1-isopropyl-1h-indol-5-yl)pyrimidin-4-yl)phenol
  参考文献：
  名称：

  Synthesis and Biological Evaluation of 2,4,5-Substituted Pyrimidines as a New Class of Tubulin Polymerization Inhibitors

  摘要：

  Members of a series of 2,4,5-substituted pyrimidine derivatives were synthesized, and their interactions with tubulin and their antiproliferative activities against the human hepatocellular carcinoma cells of liver (BEL-7402) were evaluated. One member of this family, the indole-pyrimidine 4k, having an indole-aryl-substituted aminopyrimidine structure, was observed to be an excellent inhibitor of tubulin polymerization (IC50 = 0.79 mu M) and to display significantly high antiproliferative activities against several cancer cell lines with IC50 values ranging from 16 to 62 nM. This substance displayed a high propensity to arrests cells at the G(2)/M phase of the cell cycle (EC50 = 20 nM). In addition, 4k was found to competitively inhibit colchicine binding to tubulin, indicating that it binds to the colchicine-binding site of tubulin. The observations made in this investigation demonstrate that 2,4,5-substituted pyrimidines represent a new class of tubulin polymerization inhibitors with significant antiproliferative activity.

  DOI：

  10.1021/jm101388d
• 作为产物：
  描述：

  5-溴吲哚 、 2-溴丙烷 在 potassium hydroxide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 10.0h， 以66%的产率得到5-溴-1-异丙基-1H-吲哚
  参考文献：
  名称：

  2，4-二取代嘧啶衍生物作为CDK抑制剂及其 应用

  摘要：

  本发明涉及一类2，4‑二取代嘧啶衍生物、及其作为治疗上有效的周期蛋白依赖性蛋白激酶(CDK)抑制剂的应用。具体的，本发明涉及一种通式(I)所示的新的2，4‑二取代嘧啶衍生物、及其药物组合物，作为选择性CDK4/6抑制剂在预防或治疗与CDK4/6相关疾病中的用途。

  公开号：

  CN107286134B

文献信息

• [EN] THERAPEUTIC COMPOUNDS AND USES THEREOF<br/>[FR] COMPOSÉS THÉRAPEUTIQUES ET LEURS UTILISATIONS
  申请人：GENENTECH INC

  公开号：WO2016055028A1

  公开（公告）日：2016-04-14

  The present invention relates to compounds of formula (I): and to salts thereof, wherein A has any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of CBP and/or EP300. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various CBP and/or EP300-mediated disorders.

  本发明涉及式(I)的化合物及其盐，其中A具有规范中定义的任何值，以及其组合物和用途。这些化合物可用作CBP和/或EP300的抑制剂。还包括包含式(I)的化合物或其药学上可接受的盐的药物组合物，以及在治疗各种CBP和/或EP300介导的疾病中使用这些化合物和盐的方法。
• [EN] GLUCOSYLCERAMIDE SYNTHASE INHIBITORS FOR THE TREATMENT OF DISEASES<br/>[FR] INHIBITEURS DE LA GLUCOSYLCÉRAMIDE SYNTHASE POUR LE TRAITEMENT DE MALADIES
  申请人：BIOMARIN PHARM INC

  公开号：WO2015042397A1

  公开（公告）日：2015-03-26

  Described herein are compounds of Formula I, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or conditions associated with the enzyme glucosylceramide synthase (GCS).

  本文描述了一种I式化合物，制备这种化合物的方法，含有这种化合物的药物组合物和药物，以及使用这种化合物治疗或预防与葡萄糖酰胺合成酶（GCS）相关的疾病或症状的方法。
• InCl3 mediated heteroarylation of indoles and their derivatization via C H activation strategy: Discovery of 2-(1H-indol-3-yl)-quinoxaline derivatives as a new class of PDE4B selective inhibitors for arthritis and/or multiple sclerosis
  作者：Rajnikanth Sunke、Ramudu Bankala、B. Thirupataiah、E.V.V. Shivaji Ramarao、Jetta Sandeep Kumar、Hari Maduri Doss、Raghavender Medishetti、Pushkar Kulkarni、Ravi Kumar Kapavarapu、Mahaboobkhan Rasool、Jayesh Mudgal、Jessy E. Mathew、Gautham G. Shenoy、Kishore V.L. Parsa、Manojit Pal

  DOI：10.1016/j.ejmech.2019.04.020

  日期：2019.7

  synthesized via the InCl3 mediated heteroarylation of indoles and their further derivatization through the Pd(II)-catalyzed CH activation strategy. This effort allowed us to discover a series of 2-(1H-indol-3-yl)-quinoxaline based inhibitors possessing PDE4B selectivity over PDE4D and PDE4C. One of these compounds i.e. 3b (PDE4B IC50 = 0.39 ± 0.13 μM with ∼27 and > 250 fold selectivity for PDE4B over PDE4D and

  通过InCl 3介导的吲哚杂芳基化及其通过Pd（II）催化的CH活化策略进一步衍生化，设计和合成了一类新的PDE4抑制剂。这项工作使我们能够发现一系列基于2-（1 H-吲哚-3-基）-喹喔啉的抑制剂，这些抑制剂对PDE4D和PDE4C具有PDE4B选择性。这些化合物之一即图3b（PDE4B IC 50  = 0.39±0.13  μM对PDE4B的选择性分别是PDE4D和C的〜27倍和> 250倍，在腹膜内给药3、10和30 mg / kg的斑马鱼实验性多发性硬化症自身免疫性脑脊髓炎（EAE）模型中显示了作用。实际上，它在所有这些测试剂量下都阻止了疾病的发展。在30mg / kg的腹膜内剂量下，化合物3b在佐剂诱导的关节炎大鼠中显示出有希望的作用。该化合物显着降低了关节炎大鼠的爪子体积，炎症和血管pan的形成（在膝关节中）以及促炎基因表达/ mRNA水平。此外，发现该化合物在体外对PDE4的选择性高于其他PDE家族
• Visible-Light-Mediated Ir(III)-Catalyzed Concomitant C3 Oxidation and C2 Amination of Indoles
  作者：Gaurav Shukla、Tipu Alam、Hemant Kumar Srivastava、Ritush Kumar、Bhisma K. Patel

  DOI：10.1021/acs.orglett.9b00887

  日期：2019.5.17

  A visible-light-mediated concomitant C3 oxidation and C2 amination of indoles has been achieved at room temperature using an Ir (III) photocatalyst. This reaction proceeds without an isatin intermediate via the attack of a singlet oxygen at the C3 position followed by C2 amination leading to difunctionalization of indoles.

  使用Ir（III）光催化剂在室温下实现了吲哚的可见光介导的C3氧化和C2胺化。该反应在没有靛红中间体的情况下通过在C3位上的单线态氧的攻击随后是C2的胺化导致吲哚的双官能化而进行。
• Metal‐Free TFA‐Promoted Regioselective (Hetero)Arylation: Synthesis of (Hetero)Aryl Substituted and Carbazole/Oxepine Fused <i>N</i> ‐Heterocycles
  作者：Ramanna Jatoth、Praveen Kumar Naikawadi、Boyapally Bhaskar、Kishan Gugulothu、Peramalla Edukondalu、K. Shiva Kumar

  DOI：10.1002/adsc.202101459

  日期：2022.3.30

  Metal-free TFA promoted arylation/heteroarylation was achieved under mild conditions via the reaction of chloro-derivatives of nitrogen heterocycles [e. g., =C−C(Cl)=N−] with electron rich arenes/heteroarenes. It was also observed that apart from participating in the heteroarylation step, TFA was able to facilitate the hydroarylation/o-arylation process in the same pot affording the carbazole/oxepine

  通过氮杂环的氯衍生物的反应在温和条件下实现无金属 TFA 促进的芳基化/杂芳基化[e. g.，=C-C(Cl)=N-] 与富电子芳烃/杂芳烃。还观察到，除了参与杂芳基化步骤外，TFA 还能够在同一锅中促进氢化芳基化/邻芳基化过程，从而提供咔唑/氧杂环庚烯稠合的N-杂环。该反应以克级的相似效率进行。